FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
This is in continuation of our intimation dated October 18, 2018, December 22, 2018, March 20, 2019, November 13, 2020, November 20, 2020 and April 15, 2021 with respect to an ad-interim ex-parte order passed by Securities and Exchange Board of India ('SEBI') in the matter relating to the alleged diversion of funds from the Company by its erstwhile promoters. SEBI has now issued an adjudication order no. Order/GR/KG/2022-23/16420-16458 ('Order') dated May 18, 2022, inter-alia in respect of Escorts Heart Institute and Research Centre Limited - a wholly owned subsidiary of Fortis Healthcare Limited - in the aforesaid matter. The management and Board of the Company that was newly constituted after NTK Ventures Pte. Ltd. became promoters of the Company, are evaluating the Order in detail, in consultation with their legal advisors. The detailed disclosures as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 is enclosed as 'Annexure A'.20-05-2022